MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
Resistance to cisplatin-based chemotherapy is a major cause of treatment failure in advanced bladder cancer (BC) patients. There is increasing evidence that microRNAs are involved in the development and progression of BC. However, little is known about the function of microRNAs in predicting the eff...
Main Authors: | Xin Zhang, Yanli Zhang, Xinfeng Liu, Aiju Fang, Peilong Li, Zewu Li, Tong Liu, Yongmei Yang, Lutao Du, Chuanxin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4657877?pdf=render |
Similar Items
-
MiR-203 suppresses ZNF217 upregulation in colorectal cancer and its oncogenicity.
by: Zewu Li, et al.
Published: (2015-01-01) -
Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors.
by: Angela Ferrario, et al.
Published: (2016-01-01) -
Dracorhodin perchlorate induces apoptosis in bladder cancer cells through Bcl-2, Bcl-XL, survivin down-regulation and caspase-3 activation
by: Wei Wei, et al.
Published: (2013-06-01) -
Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
by: Tong Liu, et al.
Published: (2019-03-01) -
Correction to: Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer
by: Tong Liu, et al.
Published: (2020-05-01)